BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20928914)

  • 1. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
    Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
    Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?
    Peters KM; Killinger KA; Boura JA
    Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency.
    Peters KM; Killinger KA; Ibrahim IA; Villalba PS
    Neurourol Urodyn; 2008; 27(8):775-8. PubMed ID: 18551573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment re: Killinger et al. "Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation".
    van Kerrebroeck P
    Neurourol Urodyn; 2011 Sep; 30(7):1403. PubMed ID: 21538494
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life is markedly improved in patients with fecal incontinence after sacral nerve stimulation.
    Devroede G; Giese C; Wexner SD; Mellgren A; Coller JA; Madoff RD; Hull T; Stromberg K; Iyer S;
    Female Pelvic Med Reconstr Surg; 2012; 18(2):103-12. PubMed ID: 22453321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
    van Kerrebroeck PE; van Voskuilen AC; Heesakkers JP; Lycklama á Nijholt AA; Siegel S; Jonas U; Fowler CJ; Fall M; Gajewski JB; Hassouna MM; Cappellano F; Elhilali MM; Milam DF; Das AK; Dijkema HE; van den Hombergh U
    J Urol; 2007 Nov; 178(5):2029-34. PubMed ID: 17869298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
    Daniels DH; Powell CR; Braasch MR; Kreder KJ
    Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of sacral neuromodulation in 23 children.
    Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE
    J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study.
    Haddad M; Besson R; Aubert D; Ravasse P; Lemelle J; El Ghoneimi A; Moscovici J; Hameury F; Baumstarck-Barrau K; Hery G; Guys JM
    J Urol; 2010 Aug; 184(2):696-701. PubMed ID: 20561645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral neuromodulation: long-term experience of one center.
    Elhilali MM; Khaled SM; Kashiwabara T; Elzayat E; Corcos J
    Urology; 2005 Jun; 65(6):1114-7. PubMed ID: 15913732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation in the older woman.
    McAchran SE; Daneshgari F
    Clin Obstet Gynecol; 2007 Sep; 50(3):735-44. PubMed ID: 17762421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
    Garrigues V; Mearin F; Badía X; Balboa A; Benavent J; Caballero A; Domínguez E; Díaz-Rubio M; Roset M; Figueras M; Cucala M;
    Aliment Pharmacol Ther; 2007 Feb; 25(3):323-32. PubMed ID: 17217445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
    Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can sacral neuromodulation improve minor incontinence symptoms in doubly incontinent patients successfully treated for major incontinence symptoms?
    Caremel R; Damon H; Ruffion A; Chartier-Kastler E; Gourcerol G; Michot F; Menard JF; Grise P; Leroi AM
    Urology; 2012 Jan; 79(1):80-5. PubMed ID: 22099864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study].
    Ferhi K; Miaadi N; Tanneau Y; Leroi AM; Sibert L; Grise P
    Prog Urol; 2008 Mar; 18(3):160-6. PubMed ID: 18472068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.